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in South East Asia will increase by two folds by the 
year 2025.1 
 
The World Health Organization (WHO) has estimated 
that in the year 2030, Malaysia would have a total of 
2.48 million people with DM.2 In Malaysia, the first 
National Health and Morbidity Survey I (NHMS I) 
conducted in 1986 reported a DM prevalence of 6.3% 
which had risen to 8.3% and 14.9% in the NHMS II 
(1996) and NHMS III (2006) respectively.3 In the latest 
NHMS IV 2011 report, the overall prevalence of DM 
was 15.2% and 20.8% in those aged above 18 and 30 
years respectively.4 NHMS I and II involved subjects 
aged above 30 years while NHMS III and IV were 
conducted among subjects above 18 years of age.4 
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ABSTRACT  
 
Introduction: Diabetic retinopathy (DR) is one of the commonest complications of diabetes mellitus. This 
study was to determine the prevalence of DR and its association with chronic kidney disease (CKD), high 
HbA1c and dyslipidemia among diabetic patients in government primary care clinics.  Materials and Methods: 
A cross sectional study was carried out. The respondents were selected from diabetic registry at two 
government primary care clinics in Kuantan, Pahang via stratified random sampling method during the study 
period from May 2010 to April 2011. The respondents were interviewed and assessed clinically using a 
structured questionnaire. Retinal examination was performed by accredited staff using non-mydratic retinal 
imaging and DR was classified according to the International Clinical Diabetic Retinopathy Disease Severity 
Scale. Results: Out of 400 respondents, 58.8% were diagnosed with diabetes less than 5 years and 51.0% had 
uncontrolled blood pressure (>130/80 mmHg).  The prevalence of DR and maculopathy were 33.5% and of 
17.8% respectively. Most of these patients (22.3%) had mild non-proliferative DR. DR patients had higher 
percentages CKD (17.9% vs. 6.8%; p<0.001) and a higher mean of HbA1C (8.69 vs. 8.11; p=0.015) compared 
to non-DR patients. The study revealed that DR was independently associated with CKD {OR: 3.46, 95% CI 
(1.76, 6.80)} and high HbA1c {OR: 1.12, 95% CI (1.02, 1.23)}. Those with dyslipidemia however, has 39% less 
risk of DR {OR: 0.61, 95% CI (0.39, 0.94)}. Conclusion: This study showed that diabetic patients with CKD and 
high HbA1c have greater risks to develop DR but has protective risk with dyslipidemia.  
KEYWORDS: diabetic retinopathy (DR), non-mydratic retinal camera, primary care clinic. 
INTRODUCTION 
 
Diabetes mellitus (DM) is an important public health 
concern. Globally there is a rising trend in the 
prevalence of DM due to many factors such as aging, 
urbanization and increasing prevalence of obesity 
and physical inactivity. The International Diabetes 
Federation (IDF) predicts that the prevalence of DM 
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DM is a complex disease with multiple complications 
namely nephropathy, neuropathy, retinopathy, 
dermatopathy and cardiovascular disease.13 Diabetic 
retinopathy (DR) is the leading cause of acquired 
blindness in the United States in patients aged 20 to 
74 years.5-7 Studies showed that early detection          
of diabetes, better glucose control, and early 
detection and treatment of DR can slow the 
progression of DR and prevent the development            
of blindness.8,9 Vulnerable populations, including 
minorities and the elderly are disproportionately 
affected by diabetes. They have less access to 
medical care and are therefore disproportionately 
affected by the diabetic complications, including 
DR.10,11 Effective screening and treatment programs 
can greatly reduce the burden of blindness in these 
populations.12  
 
In Malaysia, diabetic eye disease is the commonest 
cause of visual loss among adults of working age. 
Prevalence of DR is closely linked to the duration of 
DM. At the time of diagnosis, less than 5% will have 
retinopathy while the prevalence rises to 40 - 50% 
after 10 years. Almost all patients with type 1 
diabetes mellitus (T1DM) and more than 60% 
patients with type 2 diabetes mellitus (T2DM) have 
some degree of retinopathy after 20 years of the 
disease.2 
 
Hence, effort to detect DR at an early stage is 
crucial. International and national guidelines for 
screening of this disease have been published, in 
which an annual fundus examination is mandatory 
for all diabetic patients.13 Effective screening and 
treatment programmes can greatly reduce the 
burden of blindness in the vulnerable population.12 
The aim of this study was to measure the 
prevalence of DR in Kuantan population and its 
associated factors by using the Topcon TRC-NW6S 
Non-Mydriatic Camera as a sole screening 
instrument, in implementing effective screening and 
treatment programmes for diabetic patients with DR 
in primary care setting. 
 
METHODOLOGY 
 
A cross sectional study was carried out. The study 
adhered to the tenets of the declaration of Helsinki 
and was approved by Kulliyyah of Medicine research 
committee. The respondents were selected through 
stratified random sampling from the list of patients 
aged 18 years and older who attended the diabetic 
clinic in selected government primary care clinics in 
Kuantan, Pahang during the study period from 1st 
May 2010 to 30rd April 2011.  
 
The data were collected in two parts. The first part 
used the questionnaire which consists of the socio-
demographic and clinical characteristics of 
respondents. The clinical characteristics such as 
body mass index (BMI), waist circumference, blood 
pressure, systemic co-morbidity such as treated 
hypertension and dyslipidemia, chronic kidney 
disease (CKD), visual impairment and HbA1c were 
collected during the first visit.  
 
The second part was to screen the presence of 
diabetic retinopathy (DR) by using the non-mydratic 
retina camera. There were two non-mydratic retina 
cameras available at government primary care 
clinics in Kuantan located at Klinik Kesihatan (KK) 
Jaya Gading and KK Balok. All selected respondents 
were given appointments at these clinics for retinal 
photography. 
 
Retinal photography was taken using the Topcon 
TRC-NW6S Non-mydriatic Retinal Camera. It was 
performed by accredited technical staff using the 
nine-field photography. All photos were taken by 
the technicians in both clinics.  The photographic 
images were then read by a trained primary care 
physician who is the main author and the final 
findings were confirmed by the consultant 
ophthalmologist. The retinal abnormalities were 
classified according to the International Clinical 
Diabetic Retinopathy Disease Severity Scale and the 
International Clinical Diabetic Macular Oedema 
Disease Severity Scale.14 
 
The data was analyzed using the IBM Corp. SPSS 
Statistics for Windows, Version 19 Armonk, NY: IBM 
Corp. Descriptive analysis was carried out by 
calculating the frequencies and percentages for the 
categorical variables, while continuous variables 
were summarized as mean and standard deviation 
(SD). Chi-square analysis was used for categorical 
variables and for numerical variables; independent 
sample t-test was used to look for statistical 
significance of association. Logistic regression 
analyses were performed to estimate the odds ratios 
(ORs) and 95% confidence interval (CI) as the 
measure of association between CKD, high HbA1c 
and dyslipidemia with DR.  
 
13 
IMJM Volume 17 No. 2, August 2018 
The 95% CI and adjusted OR (aOR) were reported. A 
p value of < 0.05 was considered as statistically 
significant.  
 
Participation in the study was voluntary and each 
participant could withdraw from the study at any 
time. The questionnaire was accompanied by a 
cover letter explaining the purpose of the study and 
reassuring respondents of the confidentiality of the 
survey. Ethics approval was obtained from Kulliyyah 
Ethics Meeting No. 3/2009.   
 
RESULTS 
 
During the study period, 400 respondents agreed to 
be enrolled in the study. The mean (SD) age of 
patients was 51(11.1) years old. Majority were 
Malays (92.8%) and females (66.7%) with secondary 
education background (50.5%). Most of them were 
diagnosed to have diabetes mellitus (DM) for less 
Variable   No (%) 
Age (years)   51 (11.1) a 
Gender Male         
Female 
133 
267 
(33.3) 
(66.7) 
Race Malay 
Chinese 
Indian 
Others 
371 
16 
10 
3 
(92.8) 
(4.0) 
(2.5) 
(0.8) 
Education No formal 
Primary 
Secondary 
Higher 
78 
96 
202 
23 
(19.5) 
(24.3) 
(50.5) 
(5.8) 
Duration DM 
(years) 
< 1 
1-5 
> 5 
74 
161 
165 
(18.5) 
(40.3) 
(41.3) 
Smoking No 
Yes 
365 
35 
(91.3) 
(8.5) 
Table I: Socio-demographic characteristics of diabetic 
mellitus patients (n=400) 
amean (SD) 
Table II shows the clinical characteristics of 
respondents in this study. Majority of these diabetic 
patients have systemic co-morbidities such as 
hypertension and dyslipidemia.  About 10.5% of 
them have chronic kidney disease (CKD). Majority 
still have good vision (81%) and almost half of them 
have uncontrolled blood pressure. They also have 
uncontrolled DM as shown by high mean HbA1c level 
(8.3%).   
 
Variable   No (%) 
Systemic co-morbidity No                  
Yes 
68 
332 
(17.0) 
(83.0) 
Hypertension No                  
Yes 
98 
302 
(24.5) 
(75.5) 
Dyslipidemia No                  
Yes 
173 
227 
(43.3) 
(55.6) 
Chronic kidney         
diseases 
No                  
Yes 
358 
42 
(89.5) 
(10.5) 
Visual Impairment Right eye           
Left eye 
84
109 
(21.1) 
(27.3) 
Total Visual          
Impairment 
No                  
Yes 
324 
76 
(81.0) 
(19.0) 
Blood pressure 
(mmHg) 
≤ 130/80 
> 130/80 
204 
196 
(51.0) 
(49.0) 
HBA1c (%)   8.3 (2.3a) 
BMI (kg/m2)   27.8 (5.35a) 
Waist circumference   94.5 (11.53a) 
amean (SD) 
Table II: Clinical characteristics of diabetic patients 
(n=400)  
This study revealed that 134 diabetic patients had 
DR with a prevalence of 33.5%. It was also found that 
71 (17.8%) of them had both DR and diabetic 
maculopathy (Figure 1). Majority of these patients 
(22.3%) had mild non-proliferative diabetic 
retinopathy (NPDR) based on the total of number of 
eyes of diabetic patients (Figure 2). Examples of 
retinal photography taken in the study are shown in 
Figures 3 and 4.    
Figure 1: Number and percentages of diabetic retinopathy 
(DR) status in 400 diabetic patients 
Figure 2: Types of diabetic retinopathy (DR) in the total 
eyes of respondents (n = 800) 
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and ‘No Diabetic Retinopathy’ (NDR). Diabetic 
patients with DR have higher percentages of CKD 
(17.9% vs. 6.8%; p<0.001) and a higher mean of 
HbA1c (8.69 vs. 8.11; p=0.015) (Table III).  
Figure 3: Normal or no diabetic retinopathy of left eye Figure 4: Mild non-proliferative diabetic retinopathy  
NPDR with maculopathy of right eye 
There were no statistically significant differences in 
terms of age, gender, education background, 
duration of DM, history of smoking, presence of 
systemic co-morbidity and visual impairment 
between both groups of ‘Diabetic Retinopathy’ (DR) 
    
Patients without  
diabetic retinopathy 
(n = 266) 
No.(%) 
Patients with    
diabetic retinopathy 
(n = 134) 
No.(%) 
p  
valuea 
Systemic co-morbidity No 42 (15.8) 26 (19.4) 
0.364 
  Yes 224 (84.2) 108 (80.6) 
Hypertension No 60 (22.6) 38 (28.4) 
0.203 
  Yes 206 (77.4) 96 (71.6) 
Dyslipidemia No 108 (40.8) 65(48.5) 
0.132 
  Yes 158 (59.2) 69 (51.5) 
Chronic kidney didease No 248 (93.2) 110 (82.1) 
<0.001 
  Yes 18 (6.8) 24 (17.9) 
Visual impairment Right eye 58 (21.8) 26 (19.4) 0.578 
  Left eye 74 (27.8) 35 (26.1) 0.719 
Total visual impairment No 212 (79.7) 112(83.6) 
0.350 
  Yes 54(20.3) 22(16.4) 
Blood pressure (mm/Hg) ≤130/80 144(54.0) 60 (44.8) 
0.077 
  > 130/80 122(46.0) 74 (55.2) 
HbA1c (%)   8.11 (2.34)b 8.69 (2.16)b 0.015 
BMI (kg/m2)   28.1 (5.74)b 27.5 (4.47)b 0.202 
Waist circumference   94.3 (11.76)b 94.7 (11.13)b 0.769 
Unless otherwise specified, number and % values are given, acomparing between status of DR, bmean (SD).  
Table III: The clinical characteristics of Diabetic Patients by Status of DR  
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The study also revealed that DR was independently 
associated with CKD {OR: 3.46, 95% CI (1.76, 6.80)}, 
high HbA1c {OR: 1.12, 95% CI (1.02, 1.23)} and 
dyslipidemia {OR: 0.61, 95% CI (0.39, 0.94)} (Table 
IV). 
  aOR 95% CI p value 
Dyslipidemia 0.61 0.39, 0.94 0.028 
HbA1c 1.12 1.02, 1.23 0.014 
Chronic kidney 
disease 
3.46 1.76, 6.80 <0.001 
*Logistic regression  
Table IV: Multivariate Analysis* of factors associated 
with diabetic retinopathy (n = 134) 
DISCUSSION and CONCLUSION 
 
The overall prevalence of diabetic retinopathy (DR) 
and maculopathy in this study were 33.5 % and 
17.8% respectively. This result is lower than the 
national15 and Singapore Malay eye16 studies which 
showed the prevalence of DR as 36.8% and 35% 
respectively, but with higher in the prevalence of 
maculopathy (9.5% and 5.7% respectively). Another 
study at a primary care clinic in Muar showed a 
higher prevalence of DR and maculopathy (47.4% 
and 59.2% respectively).17 Most of these patients 
had mild non-proliferative diabetic retinopathy 
(NPDR), which is similar to previous studies.15-17 
 
In this study, the mean of DM duration with DR was 
5.9 years. This result is similar to previous study 
conducted at Muar17 but lower than National Eye 
Database 2007 study15 which had a mean of DM with 
DR of 9.9 years.  It’s well known that the longer a 
patient being diagnosed with DM, the greater the 
risk of attaining diabetic retinopathy.2 
 
Majority of DR patients (81%) in this study had good 
vision and only 19% of the respondents had visual 
acuity of 6/12 or worse in the better eye. Hence 
many of these diabetic patients may delay seeking 
early treatment for DR. This result is almost similar 
with previous study at a primary clinic in Muar.17 
 
The development of DR greatly depends on the 
duration of DM and the control of glucose level, 
which is measured by the level of HbA1c with odds 
ratio (OR) ranging from 1.07 to 8.62.16,18-21 In 
addition to uncontrolled glucose level other risk 
factors also played their role in the development of 
DR. This include the age of the patient, smoking 
status, the existence of other co-morbidities such as 
hypertension and dyslipidemia, body mass index, 
central obesity and renal function.16,18-21 
 
In this study, we found that uncontrolled diabetes as 
shown by high mean HbA1c (OR 1.12) or presence of 
chronic kidney disease (CKD) (OR 3.46) have high 
risks of developing DR. Interestingly, the study also 
found that diabetic patient with dyslipidemia has 
39% lower risk to develop DR which goes against 
previous studies.18-21 The use of statins in most of 
diabetic patients with dyslipidemia was shown to 
prevent the progression of DR.22-23 
 
In conclusion, the overall prevalence of DR in this 
study was 33.5% and most of these patients has had 
diabetes for less than 5 years and still presented 
with good vision. Hence, many of these diabetics 
may not be inclined to seek early eye check-up and 
treatment for DR. Diabetic patients with CKD had 
the highest risk (3.4 folds) of developing DR, which is 
followed by high HbA1c status (1.1 folds). 
Dyslipidemia on treatment was shown to have a 
protective effect from developing DR among diabetic 
patients in this study. With appropriate training, 
primary health care providers can contribute and 
support diabetic eye screening program.  
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